The kinetics of physical dependence to morphine in the rat. 1974

L Grumbach, and M Shelofsky, and J E Boston

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007977 Levallorphan An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683) Naloxiphan,Lorfan
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009021 Morphine Dependence Strong dependence, both physiological and emotional, upon morphine. Morphine Abuse,Morphine Addiction,Abuse, Morphine,Addiction, Morphine,Dependence, Morphine
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L Grumbach, and M Shelofsky, and J E Boston
April 1973, British journal of pharmacology,
L Grumbach, and M Shelofsky, and J E Boston
March 1960, Archives internationales de pharmacodynamie et de therapie,
L Grumbach, and M Shelofsky, and J E Boston
October 1978, British journal of pharmacology,
L Grumbach, and M Shelofsky, and J E Boston
June 1974, The Journal of pharmacology and experimental therapeutics,
L Grumbach, and M Shelofsky, and J E Boston
August 1972, Nature,
L Grumbach, and M Shelofsky, and J E Boston
November 1970, British journal of pharmacology,
L Grumbach, and M Shelofsky, and J E Boston
January 1992, European journal of pharmacology,
L Grumbach, and M Shelofsky, and J E Boston
January 1969, Acta physiologica latino americana,
L Grumbach, and M Shelofsky, and J E Boston
April 1971, Biochemical pharmacology,
Copied contents to your clipboard!